StudyID,term
MTBLS1,Metabolic Syndrome
MTBLS1,Gender
MTBLS2,Replicate
MTBLS2,Genotype
MTBLS3,Gene Knockout
MTBLS4,Blood Plasma
MTBLS5,Carbondioxide_Quantity_After_01D
MTBLS5,Carbondioxide_Quantity_After_Initiation
MTBLS6,Relative Intensity
MTBLS6,Gap Penalty
MTBLS6,Spike In Volume
MTBLS6,Sample Type
MTBLS6,Retention Time Modulation
MTBLS6,Min Number Ions
MTBLS6,Skewing
MTBLS6,Threshold
MTBLS6,Window
MTBLS7,Medium_After_14D
MTBLS7,Total Light_100Pc_After_Initiation
MTBLS7,Container_After_14D
MTBLS7,Total Light_100Pc_After_07D
MTBLS7,Plants/Container_Quantity_After_14D
MTBLS7,Medium_After_Initiation
MTBLS7,Total Light_0Pc_After_Initiation
MTBLS7,Total Light_0Pc_After_28D
MTBLS7,Total Light_100Pc_After_28D
MTBLS7,Container_After_Initiation
MTBLS7,Total Light_0Pc_After_07D
MTBLS8,Growth Rate
MTBLS8,Nutrient
MTBLS9,Compound
MTBLS9,Time Point
MTBLS9,Replicate
MTBLS9,Metabolite Source
MTBLS9,Batch
MTBLS10,Timepoint
MTBLS10,Treatment
MTBLS11,Medium_After_14D
MTBLS11,Total Light_100Pc_After_Initiation
MTBLS11,Container_After_14D
MTBLS11,Total Light_100Pc_After_07D
MTBLS11,Plants/Container_Quantity_After_14D
MTBLS11,Medium_After_Initiation
MTBLS11,Total Light_0Pc_After_Initiation
MTBLS11,Total Light_0Pc_After_28D
MTBLS11,Total Light_100Pc_After_28D
MTBLS11,Container_After_Initiation
MTBLS11,Total Light_0Pc_After_07D
MTBLS12,Medium_After_14D
MTBLS12,Total Light_100Pc_After_Initiation
MTBLS12,Container_After_14D
MTBLS12,Total Light_100Pc_After_07D
MTBLS12,Plants/Container_Quantity_After_14D
MTBLS12,Medium_After_Initiation
MTBLS12,Total Light_0Pc_After_Initiation
MTBLS12,Container_After_Initiation
MTBLS12,Total Light_0Pc_After_07D
MTBLS13,Medium_After_14D
MTBLS13,Total Light_100Pc_After_Initiation
MTBLS13,Container_After_14D
MTBLS13,Total Light_100Pc_After_07D
MTBLS13,Plants/Container_Quantity_After_14D
MTBLS13,Medium_After_Initiation
MTBLS13,Total Light_0Pc_After_Initiation
MTBLS13,Container_After_Initiation
MTBLS13,Total Light_0Pc_After_07D
MTBLS14,Relativehumidity_After_04D
MTBLS14,Salt_Quantity_After_16D
MTBLS14,Total Light_On_After_04D
MTBLS14,Salt_Quantity_After_08D
MTBLS14,Container_After_04D
MTBLS14,Watering_After_04D
MTBLS14,Salt_Quantity_After_12D
MTBLS14,Salt_Quantity_After_Initiation
MTBLS14,Medium_After_Initiation
MTBLS14,Total Light_Off_After_04D
MTBLS14,Medium_After_04D
MTBLS14,Container_After_Initiation
MTBLS14,Temperature_After_04D
MTBLS15,Relativehumidity_After_04D
MTBLS15,Salt_Quantity_After_16D
MTBLS15,Total Light_On_After_04D
MTBLS15,Salt_Quantity_After_08D
MTBLS15,Container_After_04D
MTBLS15,Watering_After_04D
MTBLS15,Salt_Quantity_After_12D
MTBLS15,Salt_Quantity_After_Initiation
MTBLS15,Medium_After_Initiation
MTBLS15,Total Light_Off_After_04D
MTBLS15,Medium_After_04D
MTBLS15,Container_After_Initiation
MTBLS15,Temperature_After_04D
MTBLS16,Relativehumidity_After_04D
MTBLS16,Salt_Quantity_After_16D
MTBLS16,Total Light_On_After_04D
MTBLS16,Salt_Quantity_After_08D
MTBLS16,Container_After_04D
MTBLS16,Watering_After_04D
MTBLS16,Salt_Quantity_After_12D
MTBLS16,Salt_Quantity_After_Initiation
MTBLS16,Medium_After_Initiation
MTBLS16,Total Light_Off_After_04D
MTBLS16,Medium_After_04D
MTBLS16,Container_After_Initiation
MTBLS16,Temperature_After_04D
MTBLS17,Experiment
MTBLS17,Disease
MTBLS17,Injection
MTBLS18,Sampling Time
MTBLS18,Replicate
MTBLS18,Treatment
MTBLS18,Genotype
MTBLS19,Experiment
MTBLS19,Disease
MTBLS19,Batch
MTBLS20,Material Sample
MTBLS21,Co2 Concentration
MTBLS21,Cultivation Year
MTBLS22,Salt_Quantity_After_16D
MTBLS22,Salt_Quantity_After_08D
MTBLS22,Watering_After_Initiation
MTBLS22,Salt_Quantity_After_12D
MTBLS22,Salt_Quantity_After_Initiation
MTBLS22,Salt_Quantity_After_04D
MTBLS22,Medium_After_Initiation
MTBLS22,Container_After_Initiation
MTBLS23,Treatment
MTBLS24,Time Collected Urine Sample
MTBLS24,Acute Kidney Injury
MTBLS26,Nutritional Status
MTBLS26,Genotype
MTBLS27,Sex
MTBLS27,Disease Staging
MTBLS27,Time Elapsed Between Last Radiation Therapy And Serum Collection
MTBLS27,Most Recent Treatment
MTBLS27,Age
MTBLS27,Time Elapsed Between Last Chemotherapy And Serum Collection
MTBLS28,Race
MTBLS28,Gender
MTBLS28,Smoking
MTBLS28,Sample Type
MTBLS29,Treatment
MTBLS29,Glucose Source
MTBLS29,Level Measurement Type
MTBLS29,Cell Number
MTBLS29,Timepoint
MTBLS29,Cell Line
MTBLS30,Replicate
MTBLS30,Tissue Source
MTBLS30,Feeding
MTBLS30,Genotype
MTBLS31,Dose
MTBLS31,Treatment
MTBLS31,Time
MTBLS32,Dose
MTBLS32,Treatment
MTBLS32,Time
MTBLS33,Dose
MTBLS33,Treatment
MTBLS33,Time
MTBLS34,Dose
MTBLS34,Treatment
MTBLS34,Time
MTBLS35,Harvested
MTBLS35,Growth Conditon
MTBLS35,Replication
MTBLS36,Sample Time
MTBLS36,Cultivars
MTBLS36,Batch
MTBLS37,Cell Phase
MTBLS37,Strain
MTBLS39,Year Of Harvesting
MTBLS39,Replicate
MTBLS39,Vineyard
MTBLS40,Genotype
MTBLS41,Salt_Quantity_After_16D
MTBLS41,Salt_Quantity_After_08D
MTBLS41,Watering_After_Initiation
MTBLS41,Salt_Quantity_After_12D
MTBLS41,Salt_Quantity_After_Initiation
MTBLS41,Salt_Quantity_After_04D
MTBLS41,Medium_After_Initiation
MTBLS41,Container_After_Initiation
MTBLS42,Salt_Quantity_After_16D
MTBLS42,Salt_Quantity_After_08D
MTBLS42,Watering_After_Initiation
MTBLS42,Salt_Quantity_After_12D
MTBLS42,Salt_Quantity_After_Initiation
MTBLS42,Salt_Quantity_After_04D
MTBLS42,Medium_After_Initiation
MTBLS42,Container_After_Initiation
MTBLS43,Salt_Quantity_After_Initiation
MTBLS43,Salt_Quantity_After_16D
MTBLS43,Salt_Quantity_After_08D
MTBLS43,Salt_Quantity_After_12D
MTBLS44,Salt_Quantity_After_Initiation
MTBLS44,Salt_Quantity_After_16D
MTBLS44,Salt_Quantity_After_08D
MTBLS44,Salt_Quantity_After_12D
MTBLS45,Genotype
MTBLS46,Cardiovascular Risk Status
MTBLS46,Gender
MTBLS47,Batch
MTBLS47,Genotype
MTBLS48,Time Point
MTBLS48,Chemical Exposure 
MTBLS49,Cell Density
MTBLS49,Medium
MTBLS50,Validation
MTBLS50,Sepsis Outcome
MTBLS50,Sepsis
MTBLS50,Time
MTBLS51,Validation
MTBLS51,Sepsis Outcome
MTBLS51,Sepsis
MTBLS51,Time
MTBLS52,Variety;Drought Treatment;Time Point Of Drought Duration
MTBLS53,Incubation Time;Renal Cancer Cells
MTBLS54,Salt_Quantity_After_Initiation;Salt_Quantity_After_08D;Salt_Quantity_After_12D;Salt_Quantity_After_16D
MTBLS55,Storage Type;Sample Type;Storage Time
MTBLS56,Tissue;Development Stage
MTBLS57,Stress;Genotype;Replicate
MTBLS58,Condition;Sample Growth Conditions
MTBLS59,Spiking;Apple Sample
MTBLS60,Ngada
MTBLS60,Id
MTBLS60,Sampleage
MTBLS60,Time2Diag
MTBLS60,Nia2A
MTBLS60,Nica
MTBLS60,Diagnosis
MTBLS60,Nmiaa
MTBLS60,Mo 
MTBLS60,Niaa
MTBLS60,Age
MTBLS60,Isseroc
MTBLS60,Age122Days
MTBLS60,Male
MTBLS61,Abcc6 Genotype;Gender;Ectonucleotidase Inhibition
MTBLS67,Time In Nitrogen Starvation
MTBLS69,Replicate
MTBLS70,Plant Tissue
MTBLS71,Sample Treatment Protocol;Gender
MTBLS72,Cognitive Status
MTBLS73,Cultivars;Sample Time;Batch;Acquisition Date
MTBLS74,Extraction Replicate;Injection Replicate
MTBLS75,Primary Phototrophic Cyanobacteria;Harvesting Time;Experimental Replication
MTBLS76,Sample Type;Batch Number;Plate Position
MTBLS77,Age;Genotype;Gender
MTBLS79,Batch
MTBLS81,Genotype;Nutritional Status;Total Protein In Ld;Total Acylglycerol In Ld;Age At Sacrifice
MTBLS83, Gender
MTBLS84, Gender
MTBLS85,Addition Of Tea;Storage
MTBLS86,Ethac Percentage;Sample Type
MTBLS87,Material Sample
MTBLS88,Material Sample
MTBLS89,Run Day
MTBLS89,Client Identifier
MTBLS89,Column Number
MTBLS89,Osmo
MTBLS89,Challenge Time Of Day
MTBLS89,Time Point
MTBLS89,Challenge
MTBLS89,Challenge Day
MTBLS89,Time Of Day
MTBLS89,Subject Identifier
MTBLS90,Injection Number;Spectrum Type;Age;Gender;Rmsd;Analysis Date;Season Of Sample Collection
MTBLS91,Treatment Days;Temperature;Co2 Concentration
MTBLS92,Chemotherapy Response;Series;Timepoint;T-Stage;N-Stage;Her2;Grade;Er;Menopause;Bmi
MTBLS93,Injection Number;Spectrum Type;Gender;Age;Rmsd;Analysis Date;Cluster Effect
MTBLS94,Arabidopsis;Whole Plant Development Stage;Replicate
MTBLS95,Genotype;Replicate
MTBLS96,Infection;Sample Collection;Experimental Group
MTBLS97,Systolic Blood Pressure
MTBLS97,Age
MTBLS97,Gender
MTBLS97,Smoking
MTBLS97,Bmi
MTBLS97,Diastolic Blood Pressure
MTBLS98,Genotype;Infection Stage
MTBLS99,Sample Type;Apple Number;Replicate;Batch;Injection Number
MTBLS100,Control Sample Group
MTBLS101,Gender
MTBLS102,Host Cell Line
MTBLS103,Hiae
MTBLS104,Neuropeptide Y And Y2 Receptorblocker Treatment
MTBLS105,Disease;Batch
MTBLS106,Cell Line
MTBLS107,Phytohormones;Carotenoids
MTBLS108,Phytohormones;Carotenoids
MTBLS109,Phytohormones;Carotenoids
MTBLS110,Phytohormones;Carotenoids
MTBLS111,Phytohormones;Carotenoids
MTBLS112,Treatment;Time Point;Genotype
MTBLS113,Euglena Strain;Anoxia Incubation Time;Carbonate Addition;Culture Days Before Anoxia Incubation;Colour;Temperature
MTBLS114,Caloric Restriction
MTBLS115,Trna Mistranslation;Cell Growth Phase
MTBLS116,Experiment ;Treatment;Variability Level
MTBLS117,Time Point;Infection;Replicate
MTBLS118,Time Point;Infection;Replicate
MTBLS119,Growth Year;Genotype
MTBLS120,Mutation;Chemotype
MTBLS123,Survival;Treatment;Timepoint
MTBLS124,Injection Number;Spectrum Type;Rmsd;Analysis Date;Plate Effect;Age;Gender
MTBLS125,Treatment;Tissue
MTBLS126,Base;Tissue
MTBLS127,Cell Line;Resveratrol Concentration
MTBLS128,Strain;Replicate
MTBLS129,Genotype;Time
MTBLS131,Development Stage;Truss Number
MTBLS132,Development Stage;Truss Number
MTBLS135, Gender
MTBLS136,Gender;Ageatblooddraw;Currentpmh;Secondary Identifier
MTBLS137,Variety;Country
MTBLS138, Gender
MTBLS140,Dose;Time Point;Replicate
MTBLS141,Compound
MTBLS141,Time
MTBLS142,Type 2
MTBLS142,Type 1
MTBLS142,Bisindole
MTBLS142,Type 3
MTBLS142,Monomer
MTBLS143,Treatphase1;Treatphase2;Exposuredurationphase1;Exposuredurationphase2;Testitemphase1;Testitemphase2
MTBLS144,Control;Time
MTBLS145,Exercise Protocol
MTBLS145,Time
MTBLS146,Run Order;Batch Number;Pregnancy Duration;Weight;Height;Current Chronological Age
MTBLS148,Experiment;Preservative;Timepoint;Temperature;Polarity;Sample Type;Injection Order
MTBLS149,Cholestasis;Treatment With Hljdd
MTBLS150,Cell Type;Peturbation;Time Point
MTBLS151,Genotype;Brown Planthopper Treatment;Time Course;Replicate
MTBLS152,Cell Type;Time Point
MTBLS153,Time Point
MTBLS153,Treatment
MTBLS153,Genotype
MTBLS154,Control;Time;Inorganic Phosphate
MTBLS155,Control;Time
MTBLS156,Drug Treatment;Cell Type;Incubation Time
MTBLS157,Control;Time;Carbon Source
MTBLS158, Gender
MTBLS159, Gender
MTBLS160,Genotype;Replicate
MTBLS161,Chronic Fatigue Syndrome
MTBLS162,Disease State;Bmi;Age;Gender
MTBLS163,Endocannabinoid Class;Plasma Fraction;Replicate
MTBLS164,Exercise;Diabetes;Day
MTBLS165,Panda Mother;Mother Age;Timepoint
MTBLS167,Classification
MTBLS167,Colour
MTBLS167,Year
MTBLS167,Accession Id
MTBLS168,Od600;Replicate;Deletion
MTBLS169,Genotype
MTBLS170,Mrsa_Inhibition;Sa_Inhibition
MTBLS171,Derivatisation Reagent;Derivatisation
MTBLS173,Genotype;Age;Diet
MTBLS174,Metabolic Syndrome;Steatosis ;Gender;Bmi;Age
MTBLS175,Experimental Group;Meja Treatment 
MTBLS176,Colorectal Adenocarcinoma;Mouse Kidney;Mouse Pancreas;Human Oscc;Microbial Interaction
MTBLS177,Compound;Dose;Time Post Exposure
MTBLS178,Sasang Constitution;Gender;Age
MTBLS179, Gender
MTBLS180, Gender
MTBLS181, Gender
MTBLS182,Tracer
MTBLS183,Incubation Time;Oligomycin;Glutamine;Tracer
MTBLS184,Incubation Time;Tracer
MTBLS185,Glucocorticoids
MTBLS186, Gender
MTBLS187,Time Collected;Sample Replicate;Technical Replicate Number
MTBLS188,Matrix;Spike-In Concentration
MTBLS189,Area;Drug Intervention
MTBLS190, Cardioprotection
MTBLS190,Tcm
MTBLS191,Time
MTBLS193,Time;Origin;Batch
MTBLS194,Sample Matrix
MTBLS195,Replicate
MTBLS195,Genotype
MTBLS196,Time Collected;Tissue;Virus
MTBLS197,Genotype
MTBLS198,Diet;Time;Batch
MTBLS199,Sample Type
MTBLS200,Ca Type;Timepoint;Outcome;Dis-Free Survival;Overall Survival;Dis. Prog;Staging
MTBLS201, Gender
MTBLS203,Collision Energy
MTBLS204, Gender
MTBLS205, Gender
MTBLS206, Gender
MTBLS207, Gender
MTBLS208,Nitrogen Deprivation
MTBLS209,Tissue;Species;Domestication
MTBLS210,Infection
MTBLS211,Replicate
MTBLS211,Condition
MTBLS211,Batch
MTBLS212,Treatment;Time
MTBLS213,D-Glucose;Label
MTBLS214,Osmolarity;Replicate
MTBLS215,Ionisation
MTBLS216,Experimental Group
MTBLS217,Experimental Group
MTBLS218,Time;Visit
MTBLS219,Aqp9;Sex
MTBLS220, Gender
MTBLS221, Gender
MTBLS222,Encephalopathy
MTBLS222,Phase
MTBLS223,Sample Type
MTBLS224,Region;Extract
MTBLS225,Treatment;Replicate;Dose
MTBLS226,Compound;Dose;Time Post Exposure
MTBLS227,Biol. Replicate;Tech. Replicate;Tumour Site;Stage;Cdx1/Villin;Sample Type
MTBLS228,Incubation Time
MTBLS229,Incubation Time
MTBLS230,Cell Culture Media
MTBLS231,Height
MTBLS231,Prostate Cancer Diagnosed
MTBLS231,Baseline Psa Level
MTBLS231,Age At Psa
MTBLS231,Psa Level
MTBLS231,Bmi
MTBLS231,Weight
MTBLS231,Genetic Status
MTBLS231,Cohort/Study
MTBLS232,Treatment
MTBLS232,Pre_Largest_Polyp_Removed
MTBLS232,Sample Type
MTBLS232,Red Meat Intake
MTBLS232,Gender
MTBLS232,Age
MTBLS232,Bmi
MTBLS232,Processed Red Meat
MTBLS232,Polyps_Recurrence
MTBLS232,Visit
MTBLS233,Time Point;Dose;Replicate;Scan Range
MTBLS234,Spike-In Concentration;Replicate
MTBLS235,Simulated Detector Noise;Simulated Mass Error;Simulated Error Profile Distortion
MTBLS236,Pd0332991
MTBLS236,3-13C-Glutamine
MTBLS237,Diagnosis;Age;Age At Diagnosis;Years With Disease ;Family Disposition;Smoker;Steroid Response;Steroid Dependency;Hb-Score;Mayo-Score;Extraintestinal Manifestations;Drug Treatment Asetylsalicylic Acid;Drug Treatment Local Asetylsalicylic Acid;Drug Treatment Azathioprine;Drug Treatment 6-Mercaptopurine;Drug Treatment Salazopurine;Drug Treatment Systemic Steroids;Drug Treatment Local Steroids;Drug Treatment Infliximab ;Disease Characterisation ;Extension
MTBLS238,Before Or After Training
MTBLS238,Healthy Controls
MTBLS238,Training
MTBLS239,Surgery
MTBLS239,Drug Treatment: Local Asetylsalicylic Acid
MTBLS239,Extent 
MTBLS239,Drug Treatment: Metronidazol
MTBLS239,Status
MTBLS239,Drug Treatment: Mtx
MTBLS239,Medication At Initiation
MTBLS239,Stenosis
MTBLS239,Drug Treatment: Azathioprine
MTBLS239,Hemoglobine
MTBLS239,Drug Treatment: Ciproxin
MTBLS239,Gender
MTBLS239,Smoking
MTBLS239,Drug Treatment: Isoniazid
MTBLS239,Drug Treatment: Lsb
MTBLS239,Disease
MTBLS239,Crp
MTBLS239,Fistulizing Disease
MTBLS239,Extra Intestinal Manifestations
MTBLS239,Drug Treatment: Systemic Steroid Treatment
MTBLS239,Drug Treatment: Systemic Aminosalicylic Acid
MTBLS239,Harvey Bradshaw Index And Perianal Disease Activity Index Mayo Score 
MTBLS239,Change In Medication
MTBLS239,Steroid Response
MTBLS239,Drug Treatment: Enterocort
MTBLS239,Age At Diagnosis
MTBLS239,Duration Of Disease Before Initiation
MTBLS239,Age At Sampling
MTBLS239,Drug Treatment: Local Steroids
MTBLS239,Infusion Date
MTBLS240,Diet
MTBLS241,Tracer
MTBLS242,Time Point
MTBLS243,Control
MTBLS244,Id8 Coculture;Tracer;Incubation Time
MTBLS245,Chronic Kidney Disease Stage
MTBLS245,Final Response
MTBLS245,Genetic Mutation Present
MTBLS245,Genetic Mutation
MTBLS245,Current Medication
MTBLS245,Age At 1St Manifestation
MTBLS245,Study Group
MTBLS245,Glomerular Filtration Rate
MTBLS245,Gender
MTBLS245,Proteinuria Status
MTBLS245,Disease Duration
MTBLS246,Chronic Kidney Disease Stage
MTBLS246,Final Response
MTBLS246,Genetic Mutation Present
MTBLS246,Genetic Mutation
MTBLS246,Current Medication
MTBLS246,Age At 1St Manifestation
MTBLS246,Study Group
MTBLS246,Glomerular Filtration Rate
MTBLS246,Gender
MTBLS246,Proteinuria Status
MTBLS246,Disease Duration
MTBLS247,Substrate;Labeling
MTBLS248,Injection Order
MTBLS248,Protease Inhibitor
MTBLS248,Group
MTBLS249,Copd Diagnosis;Copd Status;Pre Or Post Training Visit;Pre Or Post-Exercise;Smoking Status;Age;Gender;Bmi B/T;Bmi A/T;Ffmi B/T;Ffmi A/T;Fev;Fev Pred;Fev/Fvc Ratio;Complex Index B/T;Complex Index A/T;Tlc B/T;Tlc Pred B/T;Rv B/T;Rv Pred B/T;Ic B/T;Ic Pred B/T;Ic/Tlc Ratio;Dlco B/T;Dlco Pred B/T;Pao2;Paco2;Vo2 Peak B/T;Vo2 Peak B/T Ml/Min;Vo2 Peak Pred B/T;Vo2 Peak A/T;Vo2 Peak A/T Ml/Min;Vo2 Peak Pred A/T;Workload B/T;Workload A/T;Mvv B/T;Mvv Pred B/T;Mvv A/T;Mvv Pred A/T;Heart Rate B/T;Heart Rate Pred B/T;Heart Rate A/T;Heart Rate Pred A/T;Lactate B/T B/E;Lactate B/T A/E;Lactate A/T B/E;Lactate A/T A/E;Walk B/T;Walk A/T
MTBLS250,Injection Order
MTBLS250,Protease Inhibitor
MTBLS250,Group
MTBLS251,Phenotype
MTBLS252,Compound
MTBLS252,Diet
MTBLS252,Duration
MTBLS252,Dose
MTBLS253,Control;Phase
MTBLS254,Week
MTBLS254,Day
MTBLS254,Subject
MTBLS254,Diet
MTBLS254,Time
MTBLS255, Gender
MTBLS256,Age;Disease State
MTBLS257,Batch
MTBLS257,Age
MTBLS257,Genotype
MTBLS258,Compound
MTBLS258,Diet
MTBLS258,Physiological State
MTBLS259,Photoperiod
MTBLS260,Treatment Group;Concentration
MTBLS261,Age;Genotype
MTBLS262,Duration
MTBLS262,Treatment
MTBLS263,Injection Replicate;Preparation Replicate
MTBLS264,Sample Material;Volunteer;Timepoint
MTBLS265,Subject;Age Group
MTBLS266,Subject;Age Group
MTBLS267,Subject;Age Group
MTBLS268,Volunteer;Sample Material ;Fasting Time
MTBLS269,Mice;Sample Material;Fasting Time
MTBLS270,Variety;Temperature Of Forcing;Duration Of Forcing
MTBLS271,Anatomical Brain Region
MTBLS272,Treatment;Time;Experimental Groups
MTBLS273,Adipose Tissue;Connective Tissue;Glandular Tissue;Stroma Tissue;Tumour
MTBLS274,Sample Type
MTBLS275,Chemical Exposure
MTBLS276,Pulldown;Replicate
MTBLS277,Time Point;Nano Material;Replicate
MTBLS278,Dose;Group
MTBLS279,Control;Phase
MTBLS280,Control;Phase
MTBLS281,Sample Type;Replicate
MTBLS282,Section Location
MTBLS283,Control/Ikaros;Timepoint;Batch
MTBLS284, Gender
MTBLS285,Subject
MTBLS285,Spectrometer
MTBLS285,Replicate
MTBLS285,Tartrate Concentation
MTBLS285,Temperature
MTBLS286,Rice Seed Developmental Stage;Different Cultivar
MTBLS287,Rice Seed Developmental Stage;Different Cultivar
MTBLS288,Rice Seed Developmental Stage;Different Cultivar
MTBLS289,Patient Id;Tissue Type;Tissue Location;Specimen;Year Analysed
MTBLS290,Sample Collection Time;Sample Type
MTBLS291,Replicate
MTBLS292,Harvesting Time;Sirna;Replicate
MTBLS293,Replicate;Sampling Date
MTBLS295,Sample Type
MTBLS296,Metabolomics/Lipidomics
MTBLS297,Genotype;Organ
MTBLS298,Liver Fat;Replicate;Low Dose Insulin Infusion;Serum Type;Patient
MTBLS299, Gender
MTBLS300, Gender
MTBLS301, Gender
MTBLS302, Gender
MTBLS303,Dose;Group
MTBLS304,Group
MTBLS306,Participant;Exercise Set;Sampling Time
MTBLS307,Age;Diabetes;Gender;Mzxml Conversion Mode
MTBLS308,Dose
MTBLS308,Group
MTBLS309,Bicarbonate Treatment;Cell Type;Replicate;Incubation
MTBLS310, Gender
MTBLS311,Bicarbonate Treatment;Light Condition;Bicarbonate Concentration;Incubation;Replicate
MTBLS312,Carbon Dioxide Treatment;Incubation;Replicate
MTBLS313,Mouse Status
MTBLS314,Age
MTBLS314,Genotype
MTBLS315,Patient Group;Blood Glucose;Diff_Basophils;Diff_Eosinophils;Diff_Monocytes;Diff_Lymphocytes;Diff_Neutrophils;Platelet Count;Mean Corpuscular Hemoglobin Concentration;Mean Corpuscular Hemoglobin;Mean Corpuscular Volume;Hematocrit;Hemoglobin;Total Red Blood Cell Count;Total White Blood Cell Count;P. Falciparum Parasite Density;Temperature;Duration Illness Prior To Hospital Admission;Height;Weight;Age;Gender;Malaria Rapid Diagnostic Test;Clinical Outcome;Severe Malnutrition;Prior Antimalaria Treatment;Prior Antibiotic Treatment
MTBLS316,Glucose;Replicate
MTBLS317,Status
MTBLS318, Gender
MTBLS319,Gene Knockout;Stress;Time
MTBLS320,Geneknockout;Stress;Time
MTBLS321,Disease
MTBLS322,Nandrolone Duration;Nandrolone Dose;Tendon Release;Tendon Reattachment
MTBLS323,Sample Type;Plate Number;Plate Position
MTBLS324,Week
MTBLS324,Day
MTBLS324,Subject
MTBLS324,Diet
MTBLS324,Event
MTBLS324,Gender
MTBLS324,Timepoint
MTBLS325,Sample Material;Fasting Time;Experiment
MTBLS326,Ip3R Expression
MTBLS327,Diet;Genotype
MTBLS328,Coculture;Anaerobic;Control;Caco2;Lactobacillus Rhamnosus Lgg;Bacteroides Caccae
MTBLS330,Tissue;Life Cycle Stage;Genotype
MTBLS331,Purity
MTBLS332,Gm41;Bt03
MTBLS333,Colour;Cultivar;Cultivation Year;Location;Storage Conditions;Freezing Method
MTBLS334,Treatment ;Diet 
MTBLS335,Methanol Extraction;Tissue Type;Collision Energy
MTBLS336,Temperature
MTBLS337,Radiation;Parp Inhibitor Concentration
MTBLS338,Genotype;Replicate
MTBLS339,Time Since Blood Meal
MTBLS339,Time Point
MTBLS339,Blood Source
MTBLS339,Blood Meal Source Provided
MTBLS339,Replicate
MTBLS339,Plasmodium Infection Status
MTBLS340,Sample Type
MTBLS341,Replicate;Treatment
MTBLS342,Coral Species;Spectral Normalization
MTBLS343,Cultivar;Storage Time
MTBLS344,Fat Content
MTBLS344,Pork Content
MTBLS345,Strain;Sex;Facility;Food
MTBLS346,Cultivar;Transgene
MTBLS347,Time
MTBLS349,Tissue;Time Elapsed
MTBLS350,Cultivar;Extract;Replicate
MTBLS351,Age;Gender;Bmi;T2D Status;Homa-Ir;Metabolic Syndrome;Compound;Dose;Post Exposure Time
MTBLS352,Group
MTBLS354,Disease State
MTBLS355,Genotype;Stimulus
MTBLS356,Participant Type
MTBLS358,Study Group;Gender;Age;Bmi;Pack Year;Ethinicity
MTBLS359,Treatment;Replicate;Time
MTBLS360,Compound ;Time Post Exposure 
MTBLS361,Tissue Location;Experimental Group
MTBLS363,Elapsed Time;Replicate
MTBLS364,Smoking Status;Gender;Age
MTBLS365, Gender
MTBLS366,Station;Depth
MTBLS367,Material Sample;Time Elapsed
MTBLS368,Gender;B3 Vitamin;Time;Dosage
MTBLS369,Chronic Fatigue Syndrome
MTBLS370,Species;Extract
MTBLS371,Date Vareity
MTBLS371,Brand Name
MTBLS371,Country Of Produce
MTBLS371,Developmental Stages
MTBLS371,Replicates
MTBLS372,Phenotype;Geographic Location;Time Of First Grafting;Age At Time Of First Grafting;Dieback Score
MTBLS373,Extract;Gene;Replicate
MTBLS374,Smoking Status;Gender;Age
MTBLS375,Genotype;Time After Treatment;Replicate
MTBLS376,Antibiotic Treatment
MTBLS377,Diet
MTBLS377,Age At Tissue Harvest
MTBLS377,Strain
MTBLS377, Duration Of Special Diet
MTBLS379,Honeybee
MTBLS380,Genotype;Sampling Time;Tissue Type
MTBLS381,Spike-In Concentration
MTBLS382,Genotype;Sampling Time
MTBLS383,Species
MTBLS384,Experiment;Extraction Method;Injection Batch
MTBLS385,Patient;Tissue Type;Sex;Age
MTBLS386,Biofluid;Human State
MTBLS387,Gene Transfection
MTBLS389,Genotype;Stress;Stress Duration;Medium Additive
MTBLS390,Tissue Type;Genotype;Sampling Time
MTBLS392,Vintage;Matrix
MTBLS393,Genotype;Inducer Conditions
MTBLS395,Death Within 2 Years From Acs
MTBLS399,Plant;Location
MTBLS400,Metabolic Syndrome;Replicate;Body Weight;Liver Weight;Age
MTBLS401,Batch;Replicate
MTBLS402,Infertility
MTBLS403,Tea Type;Maufacturing Process;Withering Duration
MTBLS404,Age;Bmi;Gender;Material Type;Role;Sampling;Osmolality;Batch;Injection Order;Subset
MTBLS405,Medium;Treatment;Sample Type
MTBLS408,Run Order;Batch
MTBLS409,Replicate
MTBLS409,Age
MTBLS409,Sample Type
MTBLS410,Replicate;Parasitization;Sample Type
MTBLS411,Diet;Lactating;Multiparous
MTBLS412,Plate Surface Area;Cell Seeding Density;Medium;Isotopic Tracer;Abundance;Biological Replicate;Treatment;Incubation Time
MTBLS413,Sample Type
MTBLS414,Remote Ischemic Conditioning;Replicate;Subject
MTBLS415,Section Location
MTBLS417,Sample Group;Gender
MTBLS418,Infection
MTBLS419,Compound;Time Post Exposure
MTBLS420,Nonobstructive Azoospermia
MTBLS421,Gender
MTBLS422,Sex;Age;Treatment
MTBLS423,Lifestyle Intervention
MTBLS424,Breast Cancer Diagnosis;Breast Cancer Relapse;Histological Grade;Time To Relapse
MTBLS425,Time;Cm Source
MTBLS426,Sex;Diet
MTBLS427,Diabetes Status
MTBLS428,Sample Type;Sampling Date
MTBLS429,Sample Location
MTBLS430,Time Post Exposure;Treatment
MTBLS431,Phage Infection
MTBLS432,Genotype;Age;Inflammation
MTBLS433,Region;Variety;Production Type;Harvest Date;Fruitiness;Bitterness;Pungent;Fusty;Musty;Rancid;Oil Quality
MTBLS434,Identifier;Genotype_Commonname;Genotype_Systematicname;Batch;Analysis_Time;Sample_Type
MTBLS435,Replicate;Label;Sample Type
MTBLS436,Anabolic Treatment
MTBLS437,Protein Overexpression;Gene Suppression;Selection Marker Gene;Cultivation Technique;Postharvest Handling
MTBLS438,Infection
MTBLS439,Replicate
MTBLS440, Gender
MTBLS441,Genotype;Time After Inoculation
MTBLS442, Gender
MTBLS443,Metabolomics
MTBLS444,Tissue;Human State;Disease
MTBLS445,Elevation
MTBLS445,Location
MTBLS445,Month Of Collection
MTBLS445,Season
MTBLS445,Year Of Collection
MTBLS447,Mutant;Plant Tissue;Replicate
MTBLS448,Mutant
MTBLS449,Control;Birth Weight;Fetal Exposure During Pregnancy;Antiretroviral Therapy;Gender;Gestation Period;Maternal Age;Parturition;Ethnic Group;Maternal Viral Load;Cd4-Positive T-Lymphocytes;Time Post Exposure;Compound;Dose
MTBLS450,Mediator Arabidopsis Complex
MTBLS451,Replicate;Fermetation Process;Timepoint
MTBLS452,Treatment;Replicate;Batch
MTBLS453,Toxic Load;Experiment Duration
MTBLS454,In Vitro / In Vitro
MTBLS455,Protein Challenge
MTBLS456,Vaccination;Sample Type;Replicate
MTBLS457,Bd Exposure;Bd Exposure Date;Sample Mass;Post Mortem Dissection;Site;Site-Specific Bd Exposure;Sex;Clinical State At Time Of Death;Bd Exposed;Sham Exposed;4 Day Post-Exposure Sampling;8 Day Post-Exposure Sampling;14 Day Post-Exposure Sampling;Sampling Group;Death;Survival Duration
MTBLS458,Disease
MTBLS459,Treatment;Timepoint;Experiment;Replicate
MTBLS460,Inoculation;Time Post-Inoculation;Biological Replicate
MTBLS461,Time;Filtration;Whole Seawater
MTBLS463,Carbon Source
MTBLS464,Batch;Treatment;Timepoint;Replicate
MTBLS465,Sample Type
MTBLS467, Gender
MTBLS469,Person
MTBLS469,Meal
MTBLS469,Time Point
MTBLS469,Arm
MTBLS469,Gender
MTBLS470,Sample Type
MTBLS471,Infection;Replicate
MTBLS472,Treatment;Genotype;Replicate
MTBLS473,Time Point;Meal;Person
MTBLS475,Age
MTBLS475,Gender
MTBLS475,Type 2 Diabetes
MTBLS475,Lipid Lowering Medication
MTBLS476,Diagnostic
MTBLS478,Gene
MTBLS479,Concentration Of Willow Bark Extract;Treatment With Human Fecal Suspension;Incubation Time
MTBLS480,Extraction Solution
MTBLS481,Inoculation;Alkali Stress
MTBLS482,Treatment Concentration;Treatment
MTBLS483,Treatment Time;Replicate
MTBLS484,Pitcher Plant;Replicate
MTBLS487,Tissue Type
MTBLS488,Treatment
MTBLS491,Day
MTBLS491,Genotype
MTBLS491,Gene Knockout
MTBLS491,Medium
MTBLS491,Carbon Source
MTBLS492,Wetting Time;Successional Stage;Replicate
MTBLS493,Cell Line;Biological Replicate;Run Order;Pooled
MTBLS494,Plant Component
MTBLS495,Aging;Replicate
MTBLS496,Replicate
MTBLS496,Methanol Extract
MTBLS496,Genotype
MTBLS497,Media
MTBLS497,Time
MTBLS497,Bacteria
MTBLS516,Reperfusion Time
MTBLS516,Age
MTBLS517,Run Order;Time Point;Batch Run Order;Artemether Treatment
MTBLS518,Run Order;Time Point;Batch Run Order;Artemether Treatment
MTBLS519,Time Elapsed;Sample Type;Replicate
MTBLS520,Species;Season;Species Code;Exposition;Soil Humidity;Light Conditions;Substrate;Fresh Weight;Sample Batch Number;Lcms Date;Sample Date;Collection Season;Plant Development Stage
MTBLS521,Plant Defence
MTBLS522,Herbal Supplements
MTBLS523,Pla2G1B
MTBLS524,Case/Control
MTBLS525,Time;Replicate
MTBLS526,Time Elapsed
MTBLS526,Coronatine Treatment
MTBLS526,Sampling Time
MTBLS527,Photoaging
MTBLS528,Genotype;Replicate
MTBLS529,Replicate
MTBLS529,Genotype
MTBLS530,Genotype;Brain Region
MTBLS531,Tissue
MTBLS532,Compound
MTBLS532,Dose
MTBLS535,Species
MTBLS536,Run Order;Time Point;Batch Run Order;Artemether Treatment
MTBLS537,Gene Expression
MTBLS538,Temperature Treatment 
MTBLS538,Stress Duration
MTBLS538,Symbiotic Partner
MTBLS539,Diet
MTBLS539,Week
MTBLS539,Time Post Exposure
MTBLS540,Sample Type
MTBLS541,Oxygen Level;Cell Or Tumour
MTBLS542,Run Order;Time Point;Batch Run Order;Mean Pearsons Correlation;Artemether Treatment
MTBLS543,Diagnosis
MTBLS544,Inoculation Date
MTBLS544,Treatment
MTBLS544,Pool
MTBLS544,Genotype
MTBLS544,Replicate
MTBLS544,Sample Date
MTBLS544,Growth Chamber
MTBLS544,Tissue
MTBLS544,Plot
MTBLS545,Diet;Intervention
MTBLS546,Diet;Intervention
MTBLS547,Diet;Intervention
MTBLS548,Diet;Intervention
MTBLS549,Fasting Time
MTBLS550,Biological Replicates
MTBLS550,Genotype
MTBLS550,Time
MTBLS550,Inoculation
MTBLS552,Group
MTBLS553,Genotype;Replicates
MTBLS554,Treatment
MTBLS555,Plant Genotype;Bacterial Strain;Replicate
MTBLS557,Sex
MTBLS557,Location
MTBLS557,Volume
MTBLS557,Distance
MTBLS557,Flow
MTBLS557,Date
MTBLS557,N_Runs
MTBLS557,Tube
MTBLS558,Phenotype;Replicate;Ms Format
MTBLS559,Non-Treatment
MTBLS559,Hxa Treatment 
MTBLS559,Cultivate
MTBLS559,Aza Treatment
MTBLS559,Time Points
MTBLS559,Replacates
MTBLS560,Apparent Metabolisable Energy;Gender;Coefficient Of Digestive Utilisation Of Starch;Coefficient Of Digestive Utilisation Of Lipids;Coefficient Of Digestive Utilisation Of Nitrogen
MTBLS561,Treatment
MTBLS562,Aging;Replicate
MTBLS563,Diagnosis
MTBLS564,Diagnosis
MTBLS566,Tissue
MTBLS567,Replicate
MTBLS567,Strain
MTBLS567,Light
MTBLS567,Treatment
MTBLS570,Inflammation;Dataset
MTBLS571,Treatment
MTBLS571,Time
MTBLS572,Carbon Source
MTBLS573,Plant Defence
MTBLS574,Site;Phenotype Id
MTBLS575,Infestation;Biological Replicate;Genotype
MTBLS576,Type
MTBLS579,Carriage Status;Gender;Analytical Run Order;Fever;Right Upper Quadrant Pain;Right Upper Quadrand Tenderness;Fever 5 Days On Entry;Previous History Of Typhoid;Antibiotics 15 Days;Jaundice At Admission;Previous Jaundice;Previous Acute Cholecystitis;Previous Hospital Due To Cholecystitis;Pancreatitis;Diabetes;Gallbladder Tissue Thickness;Gall Stones;Treatment With Inj. Cefazoline;Total Cell Count;Neutrophils;Lymphocytes;Monocytes;Eosiniphils;Total Bilirubin;Conjugated Bilirubin;Aspartate Transaminase;Alanine Transaminase;Alkaline Phosphatase;Amylase
MTBLS580,Mycotoxins Treatment
MTBLS580,Control
MTBLS581,Plant Growth Regulator;Extract Type;Technical Replicates
MTBLS582,Replicate;Treatment
MTBLS585,Metabolomics
MTBLS586,Mouse T.Gondii
MTBLS588,Au Layer Test
MTBLS589,Au Layer
MTBLS591,Copd Gold Stage
MTBLS593,Dss-Inducted Colitis
MTBLS593,Mutation
MTBLS593,Recovery
MTBLS593,Gender
MTBLS593,Time Elapsed
MTBLS594,Preparation
MTBLS595,Fruit Tissue
MTBLS595,Ripening Stage 
MTBLS596,Sex
MTBLS596,Treatment
MTBLS596,Time
MTBLS596,Genotype
MTBLS597,Replicates
MTBLS598,Age;Gender;Frailty Index Score
MTBLS599,Age
MTBLS600,Age
MTBLS601,Age
MTBLS602,Genotype;Sex;Treatment;Time Of Treatment;Age
MTBLS606,Age
MTBLS607,Age
MTBLS608,Transcription Factor Expression
MTBLS609,Ph
MTBLS612,Age
MTBLS613,Gonphrena Leave
MTBLS614,Genotype;Diet
MTBLS615,Age
MTBLS616,Sampling Time
MTBLS617,Culture 
MTBLS618,Replicate
MTBLS618,Time Post Infection
MTBLS619,Diet
MTBLS619,Method
MTBLS620,Age;Disease Status;Antibody Status;Time Point
MTBLS621,Milk Dilution Before Ultrafiltration
MTBLS621,Ultrafiltration Filter Washing
MTBLS621,Comparison Of Diet
MTBLS621,Comparison Of Sample Preparationmethods
MTBLS621,Recovery Of Chosen Metabolites
MTBLS621,Visualization Of The Spectra
MTBLS622,Carbon Dioxide Treatment
MTBLS622,Virus Treatment
MTBLS623,Milk Dilution Before Ultrafiltration
MTBLS623,Ultrafiltration Filter Washing
MTBLS623,Comparison Of Diet
MTBLS623,Recovery Of Chosen Metabolites
MTBLS623,Visualization Of The Spectra
MTBLS623,Comparison Of Sample Preparation Methods
MTBLS624,Cysteine
MTBLS624,Methionine
MTBLS624,Glutamine
MTBLS624,Ph
MTBLS624,Proline
MTBLS624,Strain
MTBLS624,Arginine
MTBLS625,Condition
MTBLS625,Patient/Healthy Control
MTBLS626,Tissue Type;Treatment
MTBLS627,Id
MTBLS627,Plasma Pd5
MTBLS627,Uterus Pd5
MTBLS627,Plasma D5
MTBLS627,Uterus D5Is
MTBLS627,Uterus D5Iis
MTBLS627,Non-Id
MTBLS627,Plasma D1
MTBLS627,Plasma D4
MTBLS627,Uterus D4
MTBLS627,Uterus D1
MTBLS628,Poplar Genotypes Xylem
MTBLS629,Experimental Group
MTBLS630,Strain;Time Elapsed;Presence Of Polymyxin;Replicate
MTBLS631,Experimental Group
MTBLS633,Experimental Group
MTBLS634,Experimental Group
MTBLS636,Lipid Supplementation
MTBLS636,Replicate
MTBLS636,Organism
MTBLS638,Replicate
MTBLS638,Location
MTBLS638,Species
MTBLS638,Month
MTBLS639,Infection
MTBLS639,Time
MTBLS641,Total Mass Injected
MTBLS642,Strain Design
MTBLS642,Arabinose Supplementation Time
MTBLS642,Time
MTBLS643,Experiment
MTBLS643,Sampling Day
MTBLS644,Replicate
MTBLS644,Organism
MTBLS646,Gfr
MTBLS646,Study Number
MTBLS646,Response To Treatment
MTBLS646,Nmr Column Number
MTBLS646,Gender
MTBLS646,Age
MTBLS646,Group
MTBLS647,Drug
MTBLS647,Genotype
MTBLS648,Drug;Genotype
MTBLS652,Infection;Gene Knockout
MTBLS653,Time Collection
MTBLS654,Jeotgal
MTBLS655,Brand Name
MTBLS655,Sample Type
MTBLS656,Collection Time;Replicate
MTBLS658,Cell Number;Ns;Incubation Time;Neutrophil Activation
MTBLS661,Genotype;Batch;Replicate;Treatment
MTBLS662,Genotype
MTBLS662,Time
MTBLS663,Species
MTBLS663,Replicate
MTBLS663,Extraction
MTBLS663,Environmental Factors
MTBLS663,Strain
MTBLS664,Freeze-Thaw
MTBLS664,Run Order
MTBLS664,Batch Run Order
MTBLS664,Diagnosis
MTBLS664,Well Position
MTBLS664,Anticoagulant
MTBLS665,Run Order;Time Point;Batch Run Order;Previous Malaria Infection
MTBLS666,Age
MTBLS666,Genotype
MTBLS667,Age;Genotype
MTBLS668,Quality Control
MTBLS668,Insulin Resistance
MTBLS668,Obesity
MTBLS669,Tumor Microenvironment
MTBLS670,Sample Preparation
MTBLS671,Species
MTBLS671,Fertilized_Unfertilized
MTBLS671,Plot Type_Explo_Fert
MTBLS671,Plot Type
MTBLS671,Species Explo
MTBLS671,Plant
MTBLS671,Site
MTBLS671,Exploratory
MTBLS671,Plot
MTBLS671,Fresh Weight [Mg]
MTBLS672,Starvation Period
MTBLS673,Feeding Diets
MTBLS673,Replicate
MTBLS673,Gender
MTBLS675,Exercise
MTBLS675,Gender
MTBLS675,Age
MTBLS678,Cell/Media
MTBLS679,Season
MTBLS679,Species
MTBLS679,Designed Diversity
MTBLS679,Functional Group
MTBLS680,Drug Treatment
MTBLS680,Genotype
MTBLS682,Concentration
MTBLS682,Drug
MTBLS682,Replicate
MTBLS682,Polarity
MTBLS682,Cell Line
MTBLS682,Time
MTBLS683,Vegetable Intake
MTBLS683,Collection Time Period
MTBLS685,Genotype
MTBLS685,Drug Treatment
MTBLS685,Drug Treatment_B
MTBLS687,Species
MTBLS687,Fertilized_Unfertilized
MTBLS687,Plot Type_Explo_Fert
MTBLS687,Plot Type
MTBLS687,Species Explo
MTBLS687,Plant
MTBLS687,Site
MTBLS687,Exploratory
MTBLS687,Plot
MTBLS687,Fresh Weight [Mg]
MTBLS688,Location
MTBLS688,Species
MTBLS688,Year
MTBLS689,Time Point
MTBLS689,Run Order
MTBLS690,Gsis
MTBLS690,Year Of Birth
MTBLS690,Hba1C
MTBLS690,Gender
MTBLS690,Age
MTBLS690,Body-Mass Index
MTBLS691,Timepoint
MTBLS691,Arthemeter Treatment
MTBLS691,Well Position
MTBLS692,Gene Knockout
MTBLS692,Replicate
MTBLS692,Organ
MTBLS693,Genotype;Replicate;Tissue;Season
MTBLS694,Dilution
MTBLS695,Infected
MTBLS695,Treated
MTBLS695,Biological Replicate
MTBLS695,Technical Replicate
MTBLS696,Infected;Treated;Biological Replicate;Technical Replicate
MTBLS697,Timepoint
MTBLS697,Arthemeter Treatment
MTBLS697,Well Position
MTBLS698,Life Stage
MTBLS698,Gender
MTBLS699,Organ
MTBLS699,Ppf_Led
MTBLS699,Flowering_Period
MTBLS700,Dialysis Frequency
MTBLS700,Urea
MTBLS700,Egfr
MTBLS700,Esrd Status
MTBLS700,Gender
MTBLS700,Bmi
MTBLS700,Age
MTBLS700,Crea
MTBLS701,Replicates
MTBLS703,Replicate
MTBLS703,Cobalamin
MTBLS703,Light
MTBLS704,Two Group Classification Ms/Control
MTBLS705,Species
MTBLS706,Carbon Source
MTBLS706,Gentotype
MTBLS707,Location
MTBLS707,Species
MTBLS707,Habitat
MTBLS707,Time
MTBLS708,Replicate
MTBLS708,Cobalamin
MTBLS708,Light
MTBLS709,Season
MTBLS709,Species
MTBLS723,Gene Knock-Out
MTBLS724,Diet
MTBLS724,Genotype
MTBLS720,Amino Acid Supplementation
